Price Controls | Citizens Against Government Waste

Price Controls

Let's Not Import Bad Ideas Like International Price Indexing

How long do you think television companies would stay in business if the government told them to charge $200 for a TV even though the TV costs $250 to manufacture?  Not very long, but that is exactly what the socialists in Congress want to do with prescription drugs.

They want to use “international price indexing” (IPI) or “foreign reference pricing,” to determine the price of a drug used in the U.S. based on the price of the drug in foreign countries that use price controls and socialized medicine.

December 11, 2019 — Elizabeth Wright 1576080427

When Will Politicians Learn, Price Controls Do Not WorK?

A new bill would create an independent federal agency that would determine and regulate the cost of prescription medications.

November 14, 2019 — Elizabeth Wright 1573771216

Price Controls for Dummies

Democrats should learn what price controls REALLY mean.

October 22, 2019 — Thomas Schatz 1571775869

Importing Foreign Drugs Will Not Lower Drug Costs

This morning, the Department of Health and Human Services (HHS) announced a Notice of Proposed Rule Making (NPRM) to review two potential ways to allow “safe” importation of certain drugs originally intended for foreign markets.  No secretary of Health and Human Services or commissioner of the Food and Drug Administration (FDA) under a Republican or Democratic administration has ever confirmed that importing pharmaceuticals would keep Americans safe from da

July 31, 2019 — Elizabeth Wright 1564601270

Socialist Drug Price Controls Should be Rejected

It has been often said that in Washington, D.C. bad news comes out on a Friday afternoon and today, July 19, 2019, is no exception

July 19, 2019 — Elizabeth Wright 1563555649

Drug Price Controls Push Innovation Out of the Picture

As the debate over Speaker Nancy Pelosi’s (D-Calif.) effort to increase government control over drug pricing heats up, a familiar proposal has also drawn scrutiny.

July 11, 2019 — CAGW Staff 1562866132

House Speaker Pelosi's Bizarre Drug Price Negotiation Plan

Speaker Nancy Pelosi (D-Calif.) is expected to soon release her long-awaited drug pricing proposal.  According to news reports, the plan is expected to require the Department of Health and Human Services (HHS) to directly “negotiate” with pharmaceutical manufacturers for an “acceptable” price for at least 25 drugs that would apply to the entire U.S. market.  If no agreement can be reached, the Government Accountability Office would act as an arbitrator and oversee a dispute resolution.

June 10, 2019 — Elizabeth Wright 1560195270

U.S. Should Not Import Foreign Price Controls on Drugs

On May 20, 2019, Health and Human Services (HHS) Secretary Alex Azar, spoke before the 72nd World Health Assembly, the decision-making body of the World Health Organization (WHO) under the United Nations (UN), in Geneva, Switzerland. This assembly is held annually and attended by delegations from the 150 WHO member states, including the United States.

May 22, 2019 — Elizabeth Wright 1558556499

Conservatives Behaving Badly on Drug Pricing

Conservative politicians like to say they are for free markets, competition, and property rights to promote innovation and lower prices of goods.  But when it comes to pharmaceuticals, too many of them go careening off the freedom road to promote socialist policies.  They fail to recognize the years of expensive clinical trials and complicated protocols, the thousands of failed prospects that still must be paid for, and the lengthy Food and Drug Administration (FDA) approval process to get just one drug into the marketplace. 

May 6, 2019 — Elizabeth Wright 1557153600

Binding Arbitration for Medicare Part B: Price Controls by Another Name

The Trump administration proposed using an International Pricing Index in October 2018 to reimburse providers for drugs administered under Medicare Part B.  These drugs require the involvement of a physician and include, but are not limited to, infused and injectable drugs, some antigens, drugs used with durable medical equipment, and blood clotting factors.  Instead of reimbursing the provider of Part B d

April 24, 2019 — Elizabeth Wright 1556119688

Sign Up For Email Updates


Optional Member Code